Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Omics Characterization of Lipid Metabolic Reprogramming in People With HIV Versus HIV-Negative Metabolic Dysfunction-Associated Steatotic Liver Disease

NCT07640880 is registered in ClinicalTrials.gov with Yinzhong Shen as lead sponsor.

NCT NCT07640880
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07640880 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Omics Characterization of Lipid Metabolic Reprogramming in People With HIV Versus HIV-Negative Metabolic Dysfunction-Associated Steatotic Liver Disease
Lead sponsor
Yinzhong Shen
Phase
Observational
Overall status
Not yet recruiting
Start date
June 1, 2026
Completion date
September 1, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv (human immunodeficiency virus), masld